Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPON1,Spondin-1,Inverse variance weighted,21,1.23 [1.1-1.36],0.000141027143168865,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.49 [0.3-0.78],0.00293927014420436,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,1.09 [1.03-1.15],0.00396003483905362,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.23 [1.06-1.42],0.00646472235817104,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,APOA2,Apolipoprotein A-II,Wald ratio,1,0.41 [0.22-0.78],0.00649324108469583,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.21 [1.05-1.39],0.00784985825836262,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSO,Cathepsin O,Inverse variance weighted,6,1.3 [1.07-1.58],0.00812540505783147,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.36 [1.08-1.71],0.00966690184852193,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNC,Tenascin,Inverse variance weighted,12,0.84 [0.74-0.96],0.0116848265774665,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,20,1.15 [1.03-1.28],0.012761784263505,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.15 [1.03-1.29],0.0164130680275762,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AGRN,Agrin,Inverse variance weighted,17,0.85 [0.75-0.97],0.0172161880571328,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,10,1.2 [1.03-1.39],0.0175681109196602,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.47 [1.07-2.03],0.0179145644723859,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.11 [1.01-1.21],0.0226470118168421,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCN3,CCN family member 3,Inverse variance weighted,19,1.18 [1.02-1.37],0.0233439343722333,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RSPO1,R-spondin-1,Inverse variance weighted,5,0.82 [0.69-0.98],0.0264823704374773,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL15,Interleukin-15,Wald ratio,1,83.3 [1.67-4151.03],0.0265810387819711,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.16 [1.02-1.33],0.0286345501641191,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.14 [1.01-1.29],0.0323256323278289,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,0.95 [0.91-1],0.0334517192621321,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.07 [1.01-1.15],0.0346481323767792,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BCAN,Brevican core protein,Inverse variance weighted,3,1.25 [1.01-1.54],0.0370705688231034,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.82 [0.68-0.99],0.038273896917908,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.8 [0.64-0.99],0.038694607128548,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.36 [0.13-0.96],0.0402187632318879,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.87 [0.76-0.99],0.0416669582263762,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.89 [0.79-1],0.0426745421468653,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.07 [1-1.14],0.045161524544752,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD5L,CD5 antigen-like,Inverse variance weighted,10,0.83 [0.69-1],0.0461885130737052,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DRAXIN,Draxin,Inverse variance weighted,13,1.09 [1-1.2],0.0468185498328488,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.73 [0.53-1],0.0497280321076518,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD48,CD48 antigen,Inverse variance weighted,18,1.07 [1-1.15],0.0499964781981202,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,UMOD,Uromodulin,Inverse variance weighted,29,1.06 [1-1.12],0.0516420374720363,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.73 [0.54-1],0.0517092645043196,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD27,CD27 antigen,Inverse variance weighted,9,0.87 [0.75-1],0.0522913205550868,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,0.96 [0.92-1],0.056172136537906,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LGALS1,Galectin-1,Inverse variance weighted,6,0.88 [0.78-1],0.056924273121939,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1.04 [1-1.09],0.0569288764292944,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD46,Membrane cofactor protein,Wald ratio,1,0.63 [0.39-1.02],0.0576173552032376,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.2 [0.99-1.45],0.0582534244228492,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,2.5 [0.97-6.44],0.0586270602901965,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.2 [0.99-1.44],0.0587069491515594,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.14 [0.99-1.32],0.0596366236686666,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.1 [1-1.21],0.0597761390666736,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.3 [0.99-1.7],0.0627128130128609,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.29 [0.98-1.69],0.0653139904690323,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.13 [0.99-1.29],0.0656911324167908,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DSG2,Desmoglein-2,Inverse variance weighted,11,1.15 [0.99-1.34],0.0670200844208408,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.37 [0.98-1.93],0.0671428344422662,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.07 [0.99-1.15],0.0697134435028426,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,0.7 [0.48-1.03],0.0706178373657762,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.72 [0.5-1.03],0.0706178373657762,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.88 [0.76-1.01],0.0710060878730829,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.09 [0.99-1.2],0.0745718867673061,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AREG,Amphiregulin,Inverse variance weighted,3,1.47 [0.96-2.25],0.0754705191982693,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NRP2,Neuropilin-2,Inverse variance weighted,11,1.14 [0.99-1.32],0.0779079702063233,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,0.92 [0.84-1.01],0.0780613639317195,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.87 [0.74-1.02],0.0802186583208919,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.06 [0.99-1.14],0.081210287919862,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NFASC,Neurofascin,Inverse variance weighted,15,0.89 [0.77-1.02],0.0814688247403207,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.91 [0.92-3.95],0.0817490874452261,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NECTIN2,Nectin-2,Inverse variance weighted,5,0.9 [0.79-1.01],0.0827953615488114,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CSTB,Cystatin-B,Inverse variance weighted,28,1.08 [0.99-1.17],0.0839465362172209,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.78 [0.59-1.03],0.0840746239561968,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.25 [0.97-1.62],0.0849196614100605,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.29 [0.96-1.73],0.0863258740248453,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.86 [0.72-1.02],0.0912962780453825,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.21 [0.97-1.5],0.0916727370597813,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.73 [0.5-1.05],0.092135960677022,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.94 [0.87-1.01],0.097988835976357,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.79 [0.59-1.05],0.100469203951656,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FBLN2,Fibulin-2,Inverse variance weighted,11,1.12 [0.98-1.28],0.100875492339523,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1.09 [0.98-1.22],0.101076304356946,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.93 [0.85-1.02],0.10405174854129,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GRN,Progranulin,Inverse variance weighted,7,1.17 [0.97-1.41],0.104380978218766,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.26 [0.95-1.68],0.104898331975139,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.88 [0.76-1.03],0.105207697939743,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MB,Myoglobin,Wald ratio,1,2.55 [0.82-7.95],0.105667794401817,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.95 [0.89-1.01],0.105893122540586,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BSG,Basigin,Wald ratio,1,1.29 [0.95-1.76],0.10735718687012,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GHR,Growth hormone receptor,Inverse variance weighted,38,1.04 [0.99-1.09],0.107644615948225,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.14 [0.97-1.33],0.111665501649039,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,0.96 [0.91-1.01],0.113805476156065,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1.04 [0.99-1.08],0.113974585332467,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,0.94 [0.88-1.01],0.115544085948657,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,6,1.4 [0.92-2.12],0.115579477129978,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL17C,Interleukin-17C,Inverse variance weighted,3,0.78 [0.57-1.07],0.121082411587231,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.12 [0.97-1.29],0.123958238473187,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,1.46 [0.9-2.37],0.124037670860779,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.91 [0.81-1.03],0.124161370728672,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.32 [0.93-1.89],0.124236496951273,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.23 [0.94-1.6],0.125163645813131,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.42 [0.9-2.24],0.128773584491179,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,0.86 [0.71-1.05],0.129122756136171,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.14 [0.96-1.35],0.129427258735093,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.76 [0.53-1.09],0.132536442251509,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.8 [0.6-1.07],0.136137972171706,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.06 [0.98-1.14],0.136417472126936,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.95 [0.88-1.02],0.136438329591995,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD276,CD276 antigen,Inverse variance weighted,20,0.95 [0.88-1.02],0.145271426456025,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.42 [0.88-2.26],0.147409529693384,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.14 [0.95-1.37],0.149035897409325,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.79 [0.58-1.09],0.150264926115657,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.05 [0.98-1.12],0.151982852008755,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,0.93 [0.85-1.03],0.153451546735955,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.11 [0.96-1.28],0.156493896617288,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.75 [0.5-1.12],0.157065565916262,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.91 [0.8-1.04],0.162471321131195,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.95 [0.87-1.02],0.169241551582663,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.14 [0.95-1.38],0.169556982235438,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.61 [0.3-1.24],0.171513688533035,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.8 [0.57-1.1],0.171861240517144,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,0.93 [0.83-1.03],0.173242285352857,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,0.96 [0.91-1.02],0.17453555892629,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.76 [0.52-1.13],0.175442723674338,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.06 [0.97-1.16],0.176050167871788,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.59 [0.81-3.15],0.1806792844184,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCN4,CCN family member 4,Inverse variance weighted,27,0.95 [0.88-1.02],0.180753026483716,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.95 [0.87-1.03],0.181680525887581,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.87 [0.71-1.07],0.181978499990786,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLIN3,Perilipin-3,Wald ratio,1,0.67 [0.37-1.21],0.18287760058701,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.04 [0.98-1.1],0.185129106290855,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL10,Interleukin-10,Wald ratio,1,0.76 [0.5-1.15],0.189393759805083,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDH1,Cadherin-1,Wald ratio,1,0.54 [0.22-1.36],0.193083998259287,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.82 [0.61-1.1],0.193720877786858,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.92 [0.81-1.04],0.196097545611034,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.94 [0.86-1.03],0.197530539599355,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,4,0.85 [0.67-1.09],0.19897347002628,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,0.87 [0.7-1.08],0.202280868012934,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RTBDN,Retbindin,Inverse variance weighted,3,1.17 [0.92-1.48],0.202305247291234,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLXNB2,Plexin-B2,Inverse variance weighted,27,0.97 [0.92-1.02],0.205050996276531,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Inverse variance weighted,10,0.88 [0.73-1.07],0.205181925192798,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.9 [0.77-1.06],0.205650093755165,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHGA,Chromogranin-A,Inverse variance weighted,3,1.16 [0.92-1.45],0.206102377137966,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRSS2,Trypsin-2,Inverse variance weighted,3,0.84 [0.64-1.1],0.209817472122482,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IFNL1,Interferon lambda-1,Wald ratio,1,0.54 [0.2-1.44],0.21683398389746,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDH2,Cadherin-2,Inverse variance weighted,3,0.76 [0.49-1.18],0.21764795324753,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSL,Cathepsin L1,Wald ratio,1,1.79 [0.71-4.51],0.219856197060242,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,0.95 [0.87-1.03],0.219925638497033,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1.04 [0.98-1.11],0.221770174129376,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.31 [0.85-2.01],0.225620548968011,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.91 [0.79-1.06],0.227687078002614,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.92 [0.79-1.06],0.22977728206118,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.61 [0.28-1.36],0.23112929526593,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.13 [0.93-1.37],0.231424267451245,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,0.93 [0.83-1.05],0.232000841460476,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.83 [0.61-1.13],0.232512808121518,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.06 [0.96-1.18],0.233316149709263,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ANG,Angiogenin,Inverse variance weighted,19,1.08 [0.95-1.22],0.248680464968247,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.34 [0.81-2.19],0.25114149458308,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.25 [0.85-1.82],0.255068932143973,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VCAN,Versican core protein,Inverse variance weighted,31,0.96 [0.89-1.03],0.25871080229519,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.44 [0.76-2.7],0.261394799436778,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1.06 [0.96-1.17],0.264820741698616,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,1.28 [0.83-1.96],0.266916408529772,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.09 [0.93-1.29],0.267901915931811,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.2 [0.87-1.65],0.273186109730862,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,C7,Complement component C7,Inverse variance weighted,38,1.03 [0.98-1.08],0.275771597737718,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.05 [0.96-1.15],0.278859036910442,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,0.96 [0.9-1.03],0.279768351519545,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.95 [0.87-1.04],0.282195961310503,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.33 [0.79-2.25],0.282303068241935,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.72 [0.4-1.31],0.28353422430177,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.8 [0.54-1.2],0.28796592329716,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.92 [0.79-1.07],0.289986323018173,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.1 [0.92-1.32],0.292290497251731,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MDK,Midkine,Inverse variance weighted,4,0.84 [0.62-1.16],0.293277477348155,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.94 [0.85-1.05],0.293667526974543,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.05 [0.96-1.16],0.296199401684872,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.93 [0.8-1.07],0.296655034333923,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.97 [0.91-1.03],0.296756029569624,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LAYN,Layilin,Inverse variance weighted,20,0.92 [0.78-1.08],0.301297501825019,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.54 [0.17-1.75],0.301936610130068,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.9 [0.74-1.1],0.302920828700913,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.1 [0.91-1.34],0.302983053197723,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.94 [0.84-1.06],0.304102528695651,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.95 [0.85-1.05],0.308306092676752,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OCLN,Occludin,Inverse variance weighted,2,1.18 [0.86-1.63],0.310897535835218,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.93 [0.81-1.07],0.311051066547193,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,26,0.97 [0.92-1.03],0.315730809912885,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.15 [0.88-1.5],0.316026552355193,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.04 [0.96-1.13],0.319930354110051,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.12 [0.89-1.41],0.320543807059163,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.13 [0.89-1.42],0.322501663840086,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.04 [0.96-1.14],0.322961268852746,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.02 [0.98-1.07],0.324364395493883,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.92 [0.79-1.08],0.324714902761395,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.04 [0.96-1.14],0.325088819776539,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.04 [0.96-1.13],0.326206695693901,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHGB,Secretogranin-1,Inverse variance weighted,27,0.97 [0.9-1.04],0.327622245428321,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.94 [0.82-1.07],0.328752865081513,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.96 [0.88-1.05],0.330203798659742,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.91 [0.74-1.1],0.33035816603187,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.94 [0.83-1.07],0.333236377746451,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.63 [0.25-1.6],0.333704080980684,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.11 [0.9-1.37],0.334704678723876,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,1.05 [0.95-1.17],0.339806802466085,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COLEC12,Collectin-12,Inverse variance weighted,11,0.92 [0.77-1.09],0.345011531836313,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,THBD,Thrombomodulin,Inverse variance weighted,5,1.1 [0.9-1.36],0.350277274230762,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MSLN,Mesothelin,Inverse variance weighted,25,0.97 [0.91-1.04],0.35246844358325,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.1 [0.9-1.34],0.353417045913238,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,0.98 [0.93-1.03],0.3543579937029,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.15 [0.86-1.54],0.354817701695245,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.03 [0.96-1.11],0.355552290588751,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.1 [0.9-1.35],0.35615247314824,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.08 [0.92-1.26],0.358578027155483,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CALCA,Calcitonin,Inverse variance weighted,5,0.86 [0.62-1.19],0.361021086655433,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.27 [0.76-2.12],0.365915585393913,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.86 [0.63-1.19],0.36655247284806,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,0.88 [0.66-1.17],0.367240509515288,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.95 [0.86-1.06],0.36974284166278,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NECTIN4,Nectin-4,Inverse variance weighted,7,1.06 [0.93-1.2],0.370966352847181,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.92 [0.78-1.1],0.375588865367464,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.08 [0.91-1.3],0.37863034468148,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,0.95 [0.83-1.07],0.379518319754934,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GUCA2A,Guanylin,Inverse variance weighted,9,0.88 [0.66-1.17],0.380832430892899,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.96 [0.89-1.05],0.384461708418874,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRND,Prion-like protein doppel,Inverse variance weighted,9,1.05 [0.94-1.17],0.38860591855884,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.84 [0.57-1.24],0.388850114453039,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.91 [0.74-1.13],0.394679703382353,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,0.95 [0.85-1.07],0.395727202556017,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MPO,Myeloperoxidase,Inverse variance weighted,11,0.95 [0.86-1.06],0.396149456622137,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PALM2,Paralemmin-2,Inverse variance weighted,8,1.09 [0.9-1.32],0.398636062668532,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.06 [0.92-1.22],0.399129239829293,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1.12 [0.86-1.45],0.400733834293521,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.58 [0.54-4.61],0.404134638818199,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.93 [0.8-1.1],0.404514489007845,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLK4,Kallikrein-4,Inverse variance weighted,17,0.96 [0.87-1.06],0.406125874885926,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.79 [0.46-1.37],0.406725821751298,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RETN,Resistin,Inverse variance weighted,9,0.95 [0.83-1.08],0.411323212939473,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.97 [0.89-1.05],0.413851035950364,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.13 [0.84-1.51],0.414672050680314,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.77 [0.41-1.44],0.414812662299924,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.96 [0.87-1.06],0.417713099584563,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,16,1.04 [0.95-1.13],0.417861457162061,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDH3,Cadherin-3,Inverse variance weighted,2,0.81 [0.5-1.34],0.417986745869638,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,0.91 [0.74-1.13],0.4180825363843,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.04 [0.95-1.14],0.418650528632722,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,0.94 [0.81-1.09],0.420240269985884,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRTN3,Myeloblastin,Inverse variance weighted,21,0.96 [0.88-1.05],0.421263095406868,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ELN,Elastin,Inverse variance weighted,2,1.35 [0.65-2.8],0.422627187564641,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CFD,Complement factor D,Inverse variance weighted,11,0.95 [0.82-1.08],0.422745234566503,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RBP2,Retinol-binding protein 2,Wald ratio,1,0.75 [0.37-1.52],0.423004380119438,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.03 [0.96-1.1],0.424061904649387,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.87 [0.61-1.23],0.424080684021475,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.04 [0.94-1.15],0.42551600736934,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.69 [0.28-1.73],0.4294917947116,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.03 [0.96-1.09],0.431279773141745,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,0.91 [0.73-1.15],0.437948014606575,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PGF,Placenta growth factor,Inverse variance weighted,2,0.65 [0.22-1.93],0.438892970343519,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSS,Cathepsin S,Inverse variance weighted,23,1.03 [0.95-1.13],0.442931871205266,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLKB1,Plasma kallikrein,Inverse variance weighted,15,0.97 [0.88-1.06],0.445400001328599,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.05 [0.93-1.18],0.446696790589204,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LCAT,Phosphatidylcholine-sterol acyltransferase,Wald ratio,1,1.16 [0.78-1.73],0.449181891075491,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.15 [0.8-1.65],0.452147985645781,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LMNB2,Lamin-B2,Wald ratio,1,0.67 [0.23-1.91],0.452619357745569,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1.03 [0.95-1.11],0.455263440110034,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.94 [0.79-1.11],0.456255714983813,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PSAP,Prosaposin,Inverse variance weighted,5,0.93 [0.77-1.12],0.457317148898115,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1.08 [0.88-1.32],0.462933581546474,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,0.96 [0.88-1.06],0.467599969182729,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,0.95 [0.83-1.09],0.471879364671204,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.08 [0.88-1.32],0.473641129167357,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.04 [0.94-1.15],0.47619734967151,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.03 [0.95-1.12],0.478819055397904,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1.13 [0.8-1.6],0.479791059436693,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,0.91 [0.69-1.19],0.48069752572259,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,1.04 [0.93-1.16],0.481520362736668,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.9 [0.68-1.2],0.485318614922857,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,1.03 [0.95-1.1],0.485551339276604,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.04 [0.92-1.18],0.486374075366144,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.04 [0.92-1.18],0.490142132447563,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.26 [0.65-2.46],0.496813269466846,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.41 [0.52-3.79],0.499882782836046,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.08 [0.87-1.33],0.50042129033333,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.03 [0.95-1.12],0.502389891725114,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.98 [0.92-1.04],0.503258679025628,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.83 [0.49-1.42],0.504428928854066,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [0.96-1.09],0.504937819065577,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.06 [0.89-1.25],0.506265418234546,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.04 [0.93-1.16],0.506398473997328,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.71 [0.26-1.95],0.508390790014827,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.95 [0.81-1.11],0.511658835864276,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.04 [0.93-1.17],0.512481446297333,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LGALS9,Galectin-9,Inverse variance weighted,26,1.04 [0.93-1.15],0.516481250900009,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.95 [0.83-1.1],0.518649115392656,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.24 [0.64-2.39],0.519661717558725,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.03 [0.95-1.11],0.521802934549586,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.97 [0.88-1.06],0.524230113061623,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.97 [0.89-1.06],0.525935648074454,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.95 [0.8-1.12],0.527262370970281,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,0.94 [0.77-1.15],0.529077959865178,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,1.37 [0.51-3.68],0.532673798542587,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MATN2,Matrilin-2,Inverse variance weighted,18,0.96 [0.84-1.1],0.535385816427112,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.03 [0.93-1.15],0.536296952555541,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.05 [0.9-1.23],0.536965937486593,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.03 [0.95-1.11],0.539941761992983,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CX3CL1,Fractalkine,Inverse variance weighted,9,0.94 [0.77-1.14],0.540702883937412,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRSS8,Prostasin,Inverse variance weighted,5,1.1 [0.81-1.48],0.541707949001734,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.21 [0.66-2.22],0.541949343544309,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.96 [0.86-1.09],0.545045665005046,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.15 [0.74-1.78],0.546115837041202,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.95 [0.8-1.13],0.547219080045334,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLK8,Kallikrein-8,Inverse variance weighted,12,1.04 [0.92-1.17],0.548980708326793,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.02 [0.95-1.1],0.550006640476646,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.03 [0.93-1.15],0.551260521767321,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,1.14 [0.74-1.76],0.552453273608313,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.81 [0.4-1.63],0.552726773980164,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.2 [0.65-2.23],0.553716064521323,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VWC2,Brorin,Inverse variance weighted,22,0.97 [0.87-1.08],0.555624134615827,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.93 [0.72-1.2],0.560248901286639,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.97 [0.87-1.08],0.560687772609579,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.96 [0.82-1.11],0.561427468727941,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.02 [0.96-1.08],0.562858501134948,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.95 [0.81-1.12],0.563728869999343,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.93 [0.72-1.2],0.564749047009195,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.03 [0.94-1.13],0.566869147277498,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC3B,Tetranectin,Inverse variance weighted,7,0.95 [0.79-1.14],0.56809950882515,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.71 [0.22-2.28],0.569215706172618,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1.09 [0.8-1.5],0.569616879069506,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.97 [0.86-1.09],0.57429858995414,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,S100P,Protein S100-P,Inverse variance weighted,2,1.26 [0.56-2.85],0.575177729967803,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.94 [0.74-1.18],0.584296588858033,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.94 [0.76-1.17],0.58802653622319,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.02 [0.94-1.12],0.588619671801416,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.05 [0.87-1.28],0.589432100202303,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,0.97 [0.87-1.09],0.592024028810782,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.88 [0.56-1.4],0.594498122411532,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.96 [0.84-1.1],0.594747026043581,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.06 [0.86-1.3],0.596276594664196,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.03 [0.91-1.17],0.596339523063099,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,1.11 [0.74-1.68],0.601699809587628,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.97 [0.85-1.1],0.601821149029433,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MMP10,Stromelysin-2,Inverse variance weighted,22,0.97 [0.88-1.08],0.604341042013654,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OSM,Oncostatin-M,Wald ratio,1,1.17 [0.64-2.17],0.606342457514061,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.97 [0.87-1.08],0.606842000107231,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SERPINA11,Serpin A11,Inverse variance weighted,31,1.02 [0.95-1.09],0.609049892643788,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LGALS4,Galectin-4,Inverse variance weighted,4,0.93 [0.72-1.22],0.61023553659581,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.03 [0.92-1.16],0.61262706693596,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.95 [0.79-1.15],0.614251662569704,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.94 [0.72-1.21],0.616767634081881,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.98 [0.88-1.08],0.618609987182383,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.81 [0.35-1.86],0.624098509239593,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CALB1,Calbindin,Inverse variance weighted,2,0.89 [0.54-1.45],0.63116947687702,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.93 [0.67-1.28],0.634644314651158,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,31,1.02 [0.95-1.09],0.635395818297117,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,0.95 [0.79-1.16],0.636054960665656,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,1.04 [0.89-1.21],0.636567371226099,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,1.03 [0.91-1.18],0.637509286347148,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.03 [0.91-1.16],0.637717919970457,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LGALS3,Galectin-3,Inverse variance weighted,25,0.97 [0.87-1.09],0.64202094447757,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLK11,Kallikrein-11,Inverse variance weighted,6,1.02 [0.93-1.12],0.642156746421422,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCG3,Secretogranin-3,Inverse variance weighted,32,0.98 [0.9-1.06],0.643145166547977,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.96 [0.79-1.16],0.644043013339875,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.99 [0.94-1.04],0.644371307340711,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,1.03 [0.9-1.19],0.645944337577681,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.03 [0.9-1.19],0.648564147156344,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LCN15,Lipocalin-15,Inverse variance weighted,20,1.02 [0.94-1.1],0.649128395092631,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.07 [0.81-1.41],0.654378578621154,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AMBP,Protein AMBP,Inverse variance weighted,3,0.94 [0.71-1.25],0.661348261321734,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.88-1.08],0.661536843516025,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.95 [0.74-1.21],0.663664415415972,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.03 [0.9-1.18],0.663666405168155,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ANXA10,Annexin A10,Wald ratio,1,1.2 [0.52-2.78],0.664777684965271,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.02 [0.92-1.14],0.668324938012508,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.02 [0.95-1.09],0.669985210391156,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.93 [0.68-1.28],0.670375306515262,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EDN1,Endothelin-1,Inverse variance weighted,3,1.04 [0.86-1.27],0.670622619494035,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.99 [0.93-1.05],0.673052718467293,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.98 [0.88-1.09],0.67333506017772,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.13 [0.64-1.98],0.67338310585983,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.1 [0.7-1.72],0.674050466894114,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PYY,Peptide YY,Inverse variance weighted,6,1.04 [0.88-1.23],0.675072892230058,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.05 [0.83-1.35],0.67528603603971,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,1.07 [0.79-1.44],0.675460844820126,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.02 [0.92-1.13],0.675475129979028,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.79 [0.26-2.4],0.676567094416538,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.94 [0.7-1.27],0.677551852444637,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,15,0.97 [0.82-1.14],0.678340746116261,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.95 [0.72-1.23],0.679043624731139,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.03 [0.9-1.18],0.681713656419825,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.04 [0.88-1.23],0.6817497474502,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SELENOP,Selenoprotein P,Inverse variance weighted,2,1.08 [0.75-1.55],0.681833356114552,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.06 [0.8-1.4],0.684763621960648,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,0.99 [0.94-1.04],0.688818437607232,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SEPTIN8,Septin-8,Inverse variance weighted,2,0.94 [0.7-1.27],0.690008500939889,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD70,CD70 antigen,Inverse variance weighted,28,0.99 [0.92-1.06],0.695924724798616,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.04 [0.87-1.23],0.696892632125549,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.98 [0.87-1.1],0.704448991140638,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MMP3,Stromelysin-1,Inverse variance weighted,34,0.98 [0.9-1.08],0.705077812102744,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.98 [0.86-1.11],0.706760853275871,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.93 [0.62-1.38],0.707490450810761,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPP1,Osteopontin,Inverse variance weighted,8,0.92 [0.59-1.44],0.707546499603097,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDH6,Cadherin-6,Inverse variance weighted,29,0.99 [0.92-1.06],0.708157465380058,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,F10,Coagulation factor X,Inverse variance weighted,9,0.99 [0.92-1.06],0.711389803081768,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,0.95 [0.74-1.23],0.712555091377487,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.91 [0.55-1.51],0.71326810136987,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RGMB,RGM domain family member B,Inverse variance weighted,9,1.03 [0.86-1.24],0.713333117896103,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSV,Cathepsin L2,Inverse variance weighted,11,1.04 [0.84-1.29],0.713481104289716,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,0.93 [0.61-1.4],0.713835807161723,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD160,CD160 antigen,Inverse variance weighted,11,1.02 [0.91-1.16],0.714034360428874,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.93 [0.64-1.36],0.716551387262547,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.02 [0.92-1.13],0.72211629506293,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITGAM,Integrin alpha-M,Inverse variance weighted,3,1.05 [0.82-1.34],0.723803143496513,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PVR,Poliovirus receptor,Inverse variance weighted,27,0.99 [0.93-1.06],0.728161036452437,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.98 [0.89-1.08],0.728196763061796,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DPT,Dermatopontin,Inverse variance weighted,21,1.02 [0.91-1.14],0.728690635271434,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.02 [0.91-1.15],0.729982913097345,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Inverse variance weighted,44,0.99 [0.95-1.04],0.730428815152231,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCN5,CCN family member 5,Inverse variance weighted,8,0.94 [0.67-1.33],0.731866109039124,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.15 [0.53-2.5],0.732406507147909,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.05 [0.8-1.38],0.735550425050943,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.01 [0.94-1.09],0.735893470483768,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,0.98 [0.85-1.12],0.738650996774714,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TMSB10,Thymosin beta-10,Wald ratio,1,0.88 [0.42-1.84],0.740647027054605,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,1.2 [0.41-3.51],0.745305456692294,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.99 [0.91-1.07],0.74608336082893,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.99 [0.94-1.05],0.748270765460092,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.09 [0.65-1.81],0.75342773646492,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,0.94 [0.64-1.38],0.75436978555021,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PTN,Pleiotrophin,Inverse variance weighted,4,0.94 [0.66-1.35],0.755148005604243,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.09 [0.63-1.89],0.755834311646152,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1.02 [0.91-1.14],0.758906355115126,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REN,Renin,Inverse variance weighted,4,1.02 [0.88-1.19],0.759735729441877,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.03 [0.84-1.26],0.764094170404581,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PGA4,Pepsin A-4,Inverse variance weighted,2,0.92 [0.52-1.62],0.764129401649332,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.96 [0.73-1.26],0.76494950145004,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.02 [0.89-1.18],0.766361719869722,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCG2,Secretogranin-2,Wald ratio,1,1.15 [0.46-2.83],0.768052174404872,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.97 [0.79-1.19],0.768999870176197,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.94 [0.62-1.43],0.774401339890864,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.99 [0.91-1.07],0.778629509396778,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PROC,Vitamin K-dependent protein C,Inverse variance weighted,4,1.08 [0.62-1.88],0.77877469335336,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,XCL1,Lymphotactin,Inverse variance weighted,31,1.01 [0.94-1.09],0.779253907478607,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CST3,Cystatin-C,Inverse variance weighted,10,1.02 [0.89-1.17],0.779988484079035,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,F3,Tissue factor,Inverse variance weighted,11,0.98 [0.83-1.15],0.780457565112071,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,1.03 [0.86-1.22],0.782736350856397,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.99 [0.92-1.07],0.784833412759333,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.88 [0.35-2.2],0.786391215100514,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPON2,Spondin-2,Inverse variance weighted,4,0.97 [0.81-1.17],0.786398048527876,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.01 [0.91-1.13],0.788324594585217,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.01 [0.92-1.11],0.790144421585883,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.99 [0.89-1.09],0.791097654153395,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.95 [0.64-1.41],0.794300667426981,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,0.99 [0.91-1.07],0.79683598386546,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,1.01 [0.96-1.05],0.799224725215517,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD83,CD83 antigen,Inverse variance weighted,5,1.03 [0.8-1.33],0.800027852934915,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.97 [0.78-1.21],0.800565672622952,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.99 [0.9-1.08],0.801551519941465,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.94 [0.59-1.51],0.812928253901414,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.96 [0.67-1.37],0.813594077733601,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NPPC,C-type natriuretic peptide,Wald ratio,1,0.88 [0.32-2.47],0.814874088709704,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.11 [0.47-2.63],0.817115368259126,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,1.02 [0.89-1.16],0.817461159883833,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.01 [0.91-1.13],0.817494815333407,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,0.98 [0.84-1.15],0.818085685601141,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.05 [0.7-1.56],0.827310117009239,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.99 [0.93-1.06],0.828658330652938,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL19,Interleukin-19,Inverse variance weighted,11,1.01 [0.89-1.15],0.830375122386527,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.99 [0.87-1.12],0.831249062201125,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.03 [0.77-1.38],0.833650931984824,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.03 [0.78-1.36],0.83935564808436,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.05 [0.65-1.68],0.840577365211557,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.02 [0.84-1.24],0.842579865511795,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SDC4,Syndecan-4,Inverse variance weighted,8,1.02 [0.81-1.3],0.843749509665161,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.94 [0.5-1.78],0.847072634093536,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SDC1,Syndecan-1,Inverse variance weighted,2,0.97 [0.71-1.32],0.848288907889918,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.01 [0.88-1.17],0.854217202660829,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,5,0.98 [0.83-1.16],0.854695544772782,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.99 [0.92-1.07],0.856564527662063,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLK6,Kallikrein-6,Inverse variance weighted,4,0.98 [0.77-1.25],0.859092297519249,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ALCAM,CD166 antigen,Inverse variance weighted,6,0.97 [0.71-1.33],0.85954767531671,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.99 [0.84-1.16],0.862149233316726,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.01 [0.92-1.11],0.863573750802247,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MUC13,Mucin-13,Inverse variance weighted,9,1.02 [0.84-1.24],0.866175498117307,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.03 [0.75-1.4],0.868936085187495,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.99 [0.93-1.06],0.870993523568623,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.96 [0.6-1.55],0.872196372849489,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,0.99 [0.92-1.08],0.872638218271337,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1.01 [0.84-1.22],0.880523997689077,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.03 [0.67-1.61],0.880866587467189,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PI3,Elafin,Inverse variance weighted,10,0.99 [0.86-1.14],0.881020620975911,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NRP1,Neuropilin-1,Inverse variance weighted,12,1.01 [0.9-1.14],0.882995585580928,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1.01 [0.93-1.09],0.884944102700615,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.98 [0.8-1.21],0.885433216044472,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.01 [0.9-1.12],0.888625930074751,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DSC2,Desmocollin-2,Inverse variance weighted,9,1.01 [0.88-1.16],0.890369870206173,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.02 [0.77-1.36],0.890490271357447,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VIT,Vitrin,Inverse variance weighted,25,1 [0.94-1.07],0.89049889018169,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.96 [0.53-1.74],0.890974830356768,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.97 [0.64-1.47],0.891554877715308,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MILR1,Allergin-1,Inverse variance weighted,33,1 [0.95-1.05],0.894943046022467,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1 [0.96-1.05],0.895648063021459,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.01 [0.89-1.15],0.899955636210873,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.01 [0.9-1.13],0.900781696687457,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.01 [0.9-1.13],0.903093754426489,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.02 [0.73-1.44],0.906109744845305,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PALM,Paralemmin-1,Inverse variance weighted,6,0.99 [0.8-1.22],0.906757512298452,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.98 [0.73-1.33],0.907767781362998,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.97 [0.61-1.56],0.911639657324916,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,0.99 [0.81-1.21],0.912990236973236,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.02 [0.74-1.4],0.913383475426957,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.01 [0.91-1.12],0.913739772172172,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1 [0.94-1.06],0.914176365005609,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.02 [0.73-1.41],0.918623418746296,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.01 [0.88-1.15],0.918644954721384,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.03 [0.57-1.87],0.919503660243223,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,1.01 [0.9-1.13],0.920533414245395,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.96 [0.45-2.06],0.92057284503331,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD302,CD302 antigen,Inverse variance weighted,9,1.01 [0.87-1.16],0.925123721584395,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.06 [0.31-3.68],0.925766676109929,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.99 [0.89-1.11],0.927002770134592,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SERPINB8,Serpin B8,Inverse variance weighted,28,1 [0.95-1.05],0.929539015502546,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MVK,Mevalonate kinase,Inverse variance weighted,2,1.03 [0.54-1.94],0.932594767937347,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MMP7,Matrilysin,Inverse variance weighted,13,1 [0.9-1.13],0.933730504451385,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1 [0.89-1.13],0.936871849618811,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.01 [0.77-1.32],0.939010672021751,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.01 [0.69-1.48],0.946086907521874,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.99 [0.69-1.42],0.952380609213861,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.01 [0.76-1.34],0.952830070466621,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPO,Erythropoietin,Inverse variance weighted,5,1.02 [0.47-2.23],0.953076686492632,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFNA1,Ephrin-A1,Inverse variance weighted,11,1 [0.88-1.12],0.953749347313035,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRELP,Prolargin,Inverse variance weighted,9,1 [0.88-1.14],0.95747065160999,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.01 [0.73-1.38],0.957522922057904,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.02 [0.4-2.65],0.960216461542192,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1 [0.85-1.18],0.965541520205317,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RSPO3,R-spondin-3,Inverse variance weighted,6,0.99 [0.76-1.3],0.967343399722006,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,1.01 [0.7-1.46],0.969090145144104,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TFF1,Trefoil factor 1,Inverse variance weighted,8,1 [0.85-1.16],0.96926481161388,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PCDH1,Protocadherin-1,Wald ratio,1,1.01 [0.6-1.71],0.970179305646871,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CALB2,Calretinin,Wald ratio,1,0.99 [0.49-1.98],0.970228511059315,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,1 [0.87-1.15],0.970983059881859,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1 [0.92-1.08],0.973139329560643,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1 [0.81-1.23],0.974231643244216,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,1 [0.81-1.23],0.976805510907755,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1 [0.92-1.08],0.97784021070358,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TFF2,Trefoil factor 2,Inverse variance weighted,5,1 [0.77-1.28],0.982047917666527,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.01 [0.46-2.23],0.982358492148601,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PENK,Proenkephalin-A,Inverse variance weighted,19,1 [0.88-1.14],0.982472879321991,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.99 [0.46-2.13],0.98282189931841,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,1 [0.92-1.09],0.985674853158364,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1 [0.94-1.07],0.985900523051272,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,15,1 [0.91-1.1],0.98771380994383,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1 [0.77-1.29],0.988262267920414,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1 [0.71-1.4],0.995633401988023,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1 [0.9-1.11],0.998751574379932,cis
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.47 [1.19-1.81],0.000297778508005165,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NECTIN2,Nectin-2,Inverse variance weighted,3,3.19 [1.61-6.3],0.000842550443742505,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.56 [0.37-0.84],0.00527899178997723,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SELENOP,Selenoprotein P,Inverse variance weighted,3,2.52 [1.31-4.83],0.00553006738774335,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,1.1 [1.03-1.18],0.00672896122346642,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.36 [1.08-1.71],0.00841225133903091,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.59 [0.39-0.89],0.0129756973132561,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,1.48 [1.09-2.02],0.0131702609232368,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.4 [1.06-1.84],0.0167896417229294,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.09 [1.01-1.16],0.017841734972036,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.5 [1.07-2.1],0.018224258570903,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.71 [0.54-0.95],0.0184523993693057,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.13 [1.02-1.26],0.0228231777552987,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCN3,CCN family member 3,Inverse variance weighted,17,1.16 [1.02-1.31],0.0234215891489684,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.8 [0.65-0.97],0.0264079782952194,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.45 [1.04-2.03],0.0267581390886196,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.2 [1.02-1.41],0.027105483175484,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.71 [0.51-0.98],0.0345461211683988,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.76 [0.59-0.98],0.0355031511723096,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VIT,Vitrin,Inverse variance weighted,10,1.29 [1.02-1.63],0.0362395748593759,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.63 [1.03-2.58],0.0374818728336274,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.56 [0.32-0.97],0.0391047699783765,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.25 [1.01-1.55],0.0398057281446122,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.38 [1.02-1.87],0.0398551633308333,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SLAMF7,SLAM family member 7,Inverse variance weighted,16,0.83 [0.69-0.99],0.0408673767808842,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.22 [1.01-1.47],0.0436127972862342,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.82 [0.67-1],0.0457272983373623,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.42 [1.01-2.01],0.0462896376559292,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PCDH1,Protocadherin-1,Inverse variance weighted,4,1.37 [1-1.87],0.0474642014411554,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COLEC12,Collectin-12,Inverse variance weighted,3,0.53 [0.28-1],0.0508405177335825,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.23 [1-1.52],0.0519021475989132,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GDF15,Growth/differentiation factor 15,Wald ratio,1,3.46 [0.98-12.16],0.0530052868652275,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.49 [0.99-2.25],0.0541493077034411,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.59 [0.99-2.57],0.0551152402967362,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLK8,Kallikrein-8,Inverse variance weighted,5,0.69 [0.47-1.01],0.0556834873377397,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.93 [0.86-1],0.0567918238774984,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DSG2,Desmoglein-2,Inverse variance weighted,22,1.13 [1-1.29],0.0573104537152395,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CAPG,Macrophage-capping protein,Wald ratio,1,0.47 [0.21-1.04],0.062047961011428,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.18 [0.99-1.39],0.0621781734060448,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.28 [0.98-1.68],0.0658170886064523,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.63 [0.96-2.74],0.0679387336423003,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.75 [0.55-1.03],0.0745228361597599,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.9 [0.8-1.01],0.0769101342513131,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.8 [0.63-1.03],0.0779552632634363,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CSTB,Cystatin-B,Inverse variance weighted,23,1.08 [0.99-1.18],0.0829826316945859,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.9 [0.79-1.02],0.0844916594574951,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRELP,Prolargin,Inverse variance weighted,5,0.62 [0.35-1.08],0.0900351877177466,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LMOD1,Leiomodin-1,Inverse variance weighted,6,1.18 [0.97-1.44],0.0902512519706173,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.34 [0.95-1.88],0.0920168440064982,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.15 [0.98-1.36],0.0929914620109988,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AREG,Amphiregulin,Inverse variance weighted,5,1.39 [0.95-2.04],0.0935928378127148,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.9 [0.79-1.02],0.0958302945619548,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,38,1.11 [0.98-1.26],0.0979563553479658,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NECTIN4,Nectin-4,Inverse variance weighted,4,1.51 [0.92-2.46],0.100942574480772,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ANG,Angiogenin,Inverse variance weighted,8,0.72 [0.49-1.07],0.105387325500093,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.19 [0.96-1.48],0.106905007030064,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MVK,Mevalonate kinase,Wald ratio,1,5.94 [0.67-52.45],0.10887178297768,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.94 [0.88-1.01],0.110052002419042,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.15 [0.97-1.36],0.111043629284056,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.59 [0.31-1.13],0.111521298975784,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.1 [0.98-1.25],0.114553990384636,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.31 [0.93-1.83],0.117674996943652,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.92 [0.83-1.02],0.120584380802268,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.98 [0.82-4.76],0.126772882481012,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.51 [0.89-2.56],0.127535648915735,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.85 [0.69-1.05],0.134754687960484,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD5L,CD5 antigen-like,Inverse variance weighted,44,0.91 [0.81-1.03],0.13537510277715,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.76 [0.53-1.09],0.137693623703401,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,0.95 [0.89-1.02],0.138065621101617,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GAST,Gastrin,Inverse variance weighted,9,0.84 [0.66-1.06],0.139694308696622,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PTN,Pleiotrophin,Inverse variance weighted,3,1.41 [0.89-2.24],0.143309106654087,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.17 [0.95-1.44],0.14511139722144,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.23 [0.93-1.63],0.147983138884045,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.93 [0.85-1.03],0.151343452863351,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PPL,Periplakin,Inverse variance weighted,2,0.66 [0.38-1.17],0.153753584010129,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GOLM2,Protein GOLM2,Inverse variance weighted,14,0.91 [0.79-1.04],0.154683547974467,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,1.2 [0.93-1.56],0.155256095722679,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.1 [0.96-1.25],0.15573917821835,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LGALS3,Galectin-3,Inverse variance weighted,15,1.15 [0.95-1.4],0.161201227484764,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.78 [0.55-1.11],0.163411167715753,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1.05 [0.98-1.14],0.165144650478562,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.4 [0.87-2.26],0.167273595100005,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSS,Cathepsin S,Inverse variance weighted,7,0.8 [0.59-1.1],0.16822300502915,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.13 [0.95-1.35],0.169902856760607,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MMP10,Stromelysin-2,Wald ratio,1,0.47 [0.16-1.38],0.17006046056317,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.61 [0.3-1.24],0.171513688533035,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.63 [0.32-1.22],0.171517366046939,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL15,Interleukin-15,Inverse variance weighted,35,0.91 [0.8-1.04],0.17214736696876,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1.31 [0.89-1.95],0.175500439652656,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,0.84 [0.66-1.08],0.175800615468288,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.49 [0.84-2.66],0.176974877450796,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,1.06 [0.98-1.14],0.178548050423165,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.35 [0.87-2.1],0.178553397236913,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.15 [0.94-1.42],0.179471518631568,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,0.57 [0.25-1.29],0.179545832210558,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.1 [0.96-1.26],0.180511194445613,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.16 [0.93-1.45],0.182430402869003,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.71 [0.43-1.18],0.184646474715429,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.81 [0.59-1.11],0.185866094896172,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCG2,Secretogranin-2,Inverse variance weighted,2,1.44 [0.84-2.46],0.186402853596715,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LGALS9,Galectin-9,Inverse variance weighted,36,1.06 [0.97-1.15],0.193132618476386,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSO,Cathepsin O,Inverse variance weighted,19,0.9 [0.76-1.06],0.194088805241709,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,1.24 [0.9-1.7],0.197065672289143,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.87 [0.69-1.08],0.206518814083722,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.21 [0.9-1.63],0.206664674858822,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,0.91 [0.78-1.06],0.208553803372651,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,1.07 [0.96-1.19],0.209525605098579,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.87 [0.71-1.08],0.210041760924245,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNC,Tenascin,Inverse variance weighted,57,0.95 [0.87-1.03],0.210415044281168,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ALCAM,CD166 antigen,Inverse variance weighted,4,1.2 [0.9-1.59],0.210554762339154,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ELN,Elastin,Inverse variance weighted,10,1.2 [0.9-1.59],0.21091301705883,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDH2,Cadherin-2,Inverse variance weighted,21,0.9 [0.77-1.06],0.213063184052309,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.06 [0.97-1.15],0.21534419244158,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,0.85 [0.66-1.1],0.216821920672157,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.06 [0.96-1.17],0.218054450146973,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.39 [0.82-2.36],0.224499846527401,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.96 [0.91-1.02],0.225546424298797,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.07 [0.96-1.2],0.22855201105182,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.79 [0.53-1.16],0.229202686264702,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.85 [0.65-1.11],0.230204035632735,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.32 [0.83-2.08],0.236243671329974,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.42 [0.79-2.54],0.236418790460636,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.95 [0.86-1.04],0.239092045268332,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL19,Interleukin-19,Inverse variance weighted,10,0.93 [0.82-1.05],0.239550658826136,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.2 [0.88-1.64],0.241228779233319,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.39 [0.8-2.4],0.241249193561718,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MMP7,Matrilysin,Wald ratio,1,1.26 [0.85-1.87],0.241478464821014,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.25 [0.86-1.82],0.242270724442616,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDH1,Cadherin-1,Inverse variance weighted,16,1.09 [0.94-1.27],0.243697109596532,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,0.9 [0.76-1.07],0.247160452792542,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.17 [0.9-1.53],0.247677284093811,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.93 [0.81-1.06],0.248037547209101,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.73 [0.68-4.42],0.249364487567675,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.46 [0.76-2.8],0.254945125413035,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,1.04 [0.97-1.12],0.257508914879985,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.21 [0.87-1.7],0.260213506992949,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GRN,Progranulin,Inverse variance weighted,46,1.05 [0.97-1.14],0.260342759986391,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.21 [0.87-1.68],0.260539565401462,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.08 [0.94-1.23],0.262491227924151,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BRK1,Protein BRICK1,Inverse variance weighted,10,1.14 [0.91-1.43],0.264446345867335,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD48,CD48 antigen,Inverse variance weighted,14,0.87 [0.69-1.11],0.264926258993926,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,0.82 [0.58-1.16],0.26602048566001,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.28 [0.83-1.97],0.266123197291821,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.47 [0.74-2.9],0.268433516773053,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.27 [0.83-1.94],0.268908977777235,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,1.79 [0.64-5.04],0.269113471252289,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.17 [0.89-1.53],0.26989203166483,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD276,CD276 antigen,Inverse variance weighted,24,0.92 [0.8-1.07],0.27243154335118,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL22,Interleukin-22,Inverse variance weighted,4,1.35 [0.79-2.31],0.273988266798422,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,XG,Glycoprotein Xg,Inverse variance weighted,2,1.96 [0.59-6.53],0.274543030464318,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.83 [0.6-1.16],0.274716993884249,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.88 [0.71-1.1],0.27521524938784,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.25 [0.84-1.86],0.277861654843364,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.22 [0.85-1.76],0.278228797090039,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.21 [0.86-1.71],0.279912489984329,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.18 [0.87-1.58],0.284722701361425,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MB,Myoglobin,Inverse variance weighted,9,0.86 [0.65-1.13],0.285585667114151,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.14 [0.9-1.44],0.287577231233517,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.76 [0.46-1.26],0.287698670060656,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.11 [0.91-1.35],0.292025042272696,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.78 [0.61-5.24],0.293753643626643,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VCAN,Versican core protein,Inverse variance weighted,30,0.93 [0.82-1.06],0.295141557261531,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PGF,Placenta growth factor,Inverse variance weighted,5,1.2 [0.85-1.69],0.29540688879698,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DCN,Decorin,Inverse variance weighted,2,1.49 [0.71-3.14],0.295434851451539,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.62 [0.66-3.98],0.297549492093572,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.91 [0.76-1.09],0.298842913563175,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.15 [0.88-1.49],0.301155820661727,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.19 [0.85-1.66],0.301206100961418,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.81 [0.54-1.21],0.304866760581724,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OCLN,Occludin,Inverse variance weighted,2,1.37 [0.75-2.5],0.308942682432265,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.05 [0.95-1.17],0.309280055173493,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IFNL1,Interferon lambda-1,Inverse variance weighted,8,0.84 [0.6-1.18],0.309462866832603,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPO,Erythropoietin,Inverse variance weighted,11,0.86 [0.65-1.15],0.311757246203952,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.85 [0.61-1.17],0.31176542236533,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.81 [0.54-1.22],0.314057052331572,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.24 [0.81-1.9],0.315591322999268,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.9 [0.73-1.11],0.317264903786945,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.17 [0.86-1.6],0.319217445141104,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.8 [0.52-1.24],0.31947303271893,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.16 [0.87-1.55],0.320366270111348,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCN4,CCN family member 4,Inverse variance weighted,29,0.95 [0.87-1.05],0.32085560539843,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.33 [0.76-2.34],0.321809053973072,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.86 [0.64-1.16],0.322492503303685,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHGB,Secretogranin-1,Inverse variance weighted,7,1.14 [0.88-1.46],0.323721836871008,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.91 [0.75-1.1],0.323778805755485,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.26 [0.8-2],0.325431745037081,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.64 [0.61-4.4],0.326547260844171,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NFASC,Neurofascin,Inverse variance weighted,6,0.82 [0.55-1.23],0.328573682431491,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.12 [0.89-1.4],0.329321181672111,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.84 [0.6-1.19],0.336959266614808,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.13 [0.88-1.46],0.337010748879361,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.12 [0.89-1.42],0.337602315015728,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PENK,Proenkephalin-A,Inverse variance weighted,15,0.91 [0.76-1.1],0.339012545141062,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.07 [0.93-1.23],0.340923489757611,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.22 [0.81-1.82],0.342084809104819,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.23 [0.8-1.88],0.344041849374739,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.15 [0.85-1.56],0.35435287369221,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.86 [0.63-1.18],0.356036607794574,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.1 [0.9-1.35],0.35615247314824,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.89 [0.69-1.14],0.359049282553686,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.78 [0.47-1.32],0.361310831090868,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.61 [0.21-1.78],0.362229314991069,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.22 [0.8-1.87],0.363433246682653,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LCN15,Lipocalin-15,Inverse variance weighted,22,1.03 [0.96-1.11],0.364037739385809,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,0.87 [0.64-1.18],0.365101938445788,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL17C,Interleukin-17C,Inverse variance weighted,5,1.21 [0.8-1.84],0.368255248208247,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.96 [0.88-1.05],0.368632646594063,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.2 [0.8-1.8],0.36900771923524,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PSAP,Prosaposin,Inverse variance weighted,13,0.94 [0.82-1.08],0.369040706367638,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,0.95 [0.86-1.06],0.370104011650296,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.88 [0.66-1.17],0.37070356800788,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,0.98 [0.94-1.02],0.372352298587269,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.07 [0.92-1.24],0.372362193287592,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.11 [0.88-1.41],0.37321091272635,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.23 [0.78-1.93],0.373999115685613,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.75 [0.4-1.42],0.379849829367094,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITGAM,Integrin alpha-M,Inverse variance weighted,12,1.1 [0.89-1.36],0.381306611655195,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.04 [0.95-1.15],0.382973098573036,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.18 [0.82-1.7],0.383217478701882,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCG3,Secretogranin-3,Inverse variance weighted,16,0.92 [0.77-1.1],0.383662845414484,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.87 [0.62-1.2],0.389098153575314,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.03 [0.96-1.11],0.3898534036617,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RTBDN,Retbindin,Inverse variance weighted,2,0.78 [0.44-1.38],0.390339326730511,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CALCA,Calcitonin,Inverse variance weighted,13,1.12 [0.86-1.47],0.39219743821926,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.82 [0.53-1.28],0.392418017905259,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.22 [0.77-1.93],0.39294053428378,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.83 [0.54-1.28],0.396251981275761,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RSPO1,R-spondin-1,Inverse variance weighted,8,1.11 [0.87-1.41],0.399815072825784,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.92 [0.75-1.12],0.399845002179938,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,0.79 [0.46-1.36],0.400036186293549,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.9 [0.69-1.16],0.407022237072097,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.16 [0.82-1.64],0.412786648223055,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.93 [0.79-1.1],0.415213658196728,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.12 [0.85-1.49],0.417047434544697,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.92 [0.75-1.13],0.418237513335063,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.1 [0.87-1.4],0.420254920996644,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,11,1.1 [0.87-1.4],0.422724006664983,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCN5,CCN family member 5,Inverse variance weighted,12,0.94 [0.81-1.09],0.423684789264862,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AGRN,Agrin,Inverse variance weighted,14,0.92 [0.74-1.14],0.424475813023059,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.1 [0.87-1.39],0.425148195907801,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.13 [0.84-1.53],0.425949788285772,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.91 [0.72-1.15],0.427923101225859,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LAYN,Layilin,Inverse variance weighted,3,1.57 [0.51-4.79],0.428570232322801,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.31 [0.67-2.59],0.428968531191059,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,0.71 [0.31-1.65],0.430974141426717,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL10,Interleukin-10,Inverse variance weighted,4,0.9 [0.7-1.16],0.432027047628156,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.22 [0.74-2.02],0.432514584077567,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.07 [0.9-1.28],0.434130257370489,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.06 [0.92-1.22],0.441800708159965,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MPO,Myeloperoxidase,Inverse variance weighted,17,0.95 [0.83-1.09],0.443511555672371,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PROC,Vitamin K-dependent protein C,Inverse variance weighted,40,0.98 [0.92-1.03],0.444166945128703,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.16 [0.79-1.71],0.447048571512199,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,1.06 [0.91-1.24],0.447777167199621,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.28 [0.68-2.39],0.449525035922055,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.04 [0.94-1.14],0.449574483329761,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.04 [0.93-1.17],0.450337726461966,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.94 [0.79-1.11],0.452938725915862,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,3,1.36 [0.61-3.07],0.454524450997292,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PALM2,Paralemmin-2,Inverse variance weighted,9,1.07 [0.89-1.29],0.45456741458737,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,1.36 [0.61-3.03],0.455264696811301,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.17 [0.78-1.76],0.458017862121125,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLK6,Kallikrein-6,Inverse variance weighted,2,1.24 [0.7-2.2],0.459001370828741,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SERPINA11,Serpin A11,Inverse variance weighted,14,0.9 [0.67-1.2],0.459527135151631,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.12 [0.83-1.5],0.459553066610466,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.93 [0.75-1.14],0.461096552181916,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MMP3,Stromelysin-1,Inverse variance weighted,4,1.24 [0.7-2.18],0.462748059476927,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GUCA2A,Guanylin,Inverse variance weighted,7,0.87 [0.61-1.26],0.462842529258635,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.91 [0.71-1.17],0.463639692302639,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.31 [0.64-2.7],0.463756983931868,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.03 [0.95-1.13],0.466007176492012,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,1.13 [0.81-1.56],0.46704182241708,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.06 [0.91-1.22],0.468214360024321,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.08 [0.88-1.31],0.469242362101202,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.17 [0.76-1.81],0.46983138757133,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.35 [0.6-3.02],0.469937483264831,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,0.94 [0.79-1.12],0.470308542983205,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.06 [0.91-1.24],0.470689193803906,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.89 [0.65-1.22],0.4711137263493,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NRP2,Neuropilin-2,Inverse variance weighted,14,1.09 [0.86-1.38],0.480388818596427,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.11 [0.83-1.47],0.480584642808535,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RSPO3,R-spondin-3,Inverse variance weighted,5,0.88 [0.61-1.26],0.482152123929041,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.92 [0.72-1.17],0.486550407945504,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD99,CD99 antigen,Inverse variance weighted,4,1.13 [0.8-1.61],0.488660463360315,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.97 [0.9-1.05],0.488867704678316,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.93 [0.75-1.15],0.488890887852531,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.89 [0.65-1.23],0.48953569002963,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.8 [0.43-1.5],0.490298749291369,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.03 [0.95-1.12],0.490898039016186,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.1 [0.84-1.43],0.492537429659235,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.11 [0.81-1.52],0.498124311738063,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.1 [0.84-1.44],0.4983251217178,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.19 [0.72-1.98],0.499364619041495,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.75 [0.33-1.72],0.501868084123646,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.04 [0.92-1.18],0.503872731645155,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPON2,Spondin-2,Inverse variance weighted,3,0.82 [0.46-1.46],0.504202931023613,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,0.69 [0.23-2.06],0.505339675274521,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.88 [0.61-1.27],0.505392562433327,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.21 [0.69-2.1],0.505590096744762,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.15 [0.76-1.76],0.506700467730585,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,0.85 [0.53-1.37],0.507970441816881,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.85 [0.53-1.37],0.509521139436969,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.12 [0.79-1.59],0.512378119621699,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.91 [0.67-1.22],0.514172714728532,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRND,Prion-like protein doppel,Inverse variance weighted,15,0.93 [0.76-1.15],0.520130357687522,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.1 [0.82-1.47],0.520832054026296,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.94 [0.77-1.14],0.522460869576025,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.93 [0.76-1.15],0.522504084656428,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PYY,Peptide YY,Inverse variance weighted,16,1.04 [0.91-1.19],0.526429325174803,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.97 [0.87-1.07],0.527498666192404,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.88 [0.58-1.32],0.527691821291715,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.9 [0.64-1.26],0.528752141406372,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.92 [0.7-1.21],0.530350170568631,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.96 [0.85-1.09],0.531831875565598,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.12 [0.78-1.6],0.53372004768923,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.2 [0.68-2.11],0.535540431612994,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.96 [0.85-1.09],0.537753810140657,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.33 [0.54-3.26],0.539285195215546,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.91-1.05],0.543907251483008,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LGALS4,Galectin-4,Inverse variance weighted,15,1.03 [0.93-1.15],0.544665156045318,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.7 [0.22-2.24],0.545528068584203,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.06 [0.88-1.27],0.545759918744757,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.14 [0.75-1.74],0.546250642084323,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,0.95 [0.81-1.12],0.546980552076966,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.38 [0.49-3.91],0.547047646318359,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.12 [0.78-1.6],0.55382782530174,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.07 [0.85-1.34],0.558567184153656,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.22 [0.62-2.4],0.560149034804518,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CFD,Complement factor D,Wald ratio,1,0.77 [0.31-1.88],0.560599835942258,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.81 [0.4-1.64],0.561258962641497,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CX3CL1,Fractalkine,Inverse variance weighted,12,1.08 [0.84-1.39],0.566529797654872,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SDC1,Syndecan-1,Inverse variance weighted,12,0.94 [0.76-1.16],0.568210185737876,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.06 [0.87-1.29],0.569192720097976,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.14 [0.72-1.83],0.572317986441285,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSL,Cathepsin L1,Inverse variance weighted,29,0.95 [0.8-1.13],0.575675044768779,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD70,CD70 antigen,Inverse variance weighted,11,1.06 [0.87-1.29],0.577197600640164,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.97 [0.88-1.07],0.577328257071012,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,WNT9A,Protein Wnt-9a,Wald ratio,1,1.4 [0.42-4.67],0.581367423576659,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.03 [0.93-1.14],0.583223571340123,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLK11,Kallikrein-11,Inverse variance weighted,13,1.06 [0.86-1.31],0.592728250713565,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CST3,Cystatin-C,Inverse variance weighted,3,0.85 [0.48-1.52],0.594798033770042,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.05 [0.89-1.23],0.596004086083198,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.97 [0.87-1.08],0.596094644926023,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.08 [0.81-1.46],0.597513024737307,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BCAN,Brevican core protein,Inverse variance weighted,12,1.08 [0.8-1.46],0.603587070182817,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.14 [0.69-1.88],0.607063532817387,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.06 [0.84-1.35],0.607504064004653,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1.02 [0.95-1.1],0.608363846258461,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.18 [0.63-2.19],0.608817390965576,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.63 [0.25-10.75],0.610055748059557,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.07 [0.82-1.4],0.610155441219708,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDH3,Cadherin-3,Inverse variance weighted,10,1.07 [0.83-1.37],0.61572077120964,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OSM,Oncostatin-M,Inverse variance weighted,6,1.07 [0.82-1.39],0.616988290651358,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SEPTIN8,Septin-8,Inverse variance weighted,4,0.89 [0.56-1.41],0.617940068802911,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.04 [0.88-1.24],0.621825705138347,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.04 [0.89-1.23],0.623502931573006,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.81 [0.35-1.86],0.624098509239593,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.97 [0.86-1.1],0.629631813034977,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.93 [0.67-1.27],0.630885704770372,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.91 [0.63-1.32],0.632306370889132,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPP1,Osteopontin,Inverse variance weighted,13,1.08 [0.78-1.49],0.633279469009315,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD160,CD160 antigen,Inverse variance weighted,24,1.05 [0.86-1.27],0.639654695843077,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.96 [0.8-1.15],0.639899708477028,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,1.18 [0.58-2.4],0.644736031604603,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,1.04 [0.89-1.21],0.645080107429485,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.92 [0.64-1.32],0.649054856259882,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.03 [0.92-1.15],0.650068156400053,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.25 [0.47-3.37],0.651938279189931,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CALB1,Calbindin,Inverse variance weighted,9,1.06 [0.82-1.36],0.653073041549506,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MATN2,Matrilin-2,Inverse variance weighted,28,0.98 [0.91-1.06],0.653292706026873,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.06 [0.83-1.35],0.654449244300191,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.11 [0.71-1.71],0.655130487767661,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL6,Interleukin-6,Inverse variance weighted,6,1.05 [0.84-1.32],0.659461104226057,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.95 [0.74-1.21],0.660708674080476,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.18 [0.56-2.46],0.662793475368269,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.16 [0.6-2.22],0.663212310473084,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.98 [0.92-1.05],0.663910628378107,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.05 [0.85-1.28],0.664898457902553,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.97 [0.84-1.12],0.666601225120663,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.04 [0.88-1.23],0.666849794740367,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,0.91 [0.61-1.38],0.666855022732082,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,0.96 [0.8-1.16],0.673218434614245,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,0.97 [0.86-1.1],0.67344181127725,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.97 [0.84-1.12],0.675947864543355,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OGN,Mimecan,Inverse variance weighted,37,0.98 [0.89-1.08],0.677202181617993,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.03 [0.88-1.22],0.677629876763581,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.96 [0.81-1.15],0.679971850837048,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.82 [0.32-2.1],0.680259686052284,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.88 [0.48-1.61],0.680369178811548,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,21,0.96 [0.79-1.17],0.680939695921869,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.89 [0.51-1.57],0.686725339430708,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.71 [0.14-3.7],0.686860165477829,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD302,CD302 antigen,Inverse variance weighted,11,0.96 [0.78-1.18],0.688586997291354,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.14 [0.6-2.15],0.691866199435165,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.97 [0.83-1.14],0.693805665809602,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.01 [0.94-1.09],0.694168493081364,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,1.04 [0.85-1.27],0.694703051777669,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1.03 [0.9-1.18],0.694922757074398,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.94 [0.68-1.3],0.695446774536987,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,0.98 [0.9-1.07],0.695700093525444,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.1 [0.67-1.83],0.699918565303272,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,0.94 [0.71-1.26],0.700811401712969,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,25,1.03 [0.89-1.19],0.70408465356403,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.14 [0.57-2.29],0.705055963639554,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.03 [0.88-1.2],0.707603474716968,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.2 [0.46-3.09],0.708570773053913,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1.01 [0.95-1.09],0.709381653294358,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,F10,Coagulation factor X,Inverse variance weighted,11,0.96 [0.76-1.2],0.710983531920781,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.06 [0.78-1.43],0.711957425373084,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.97 [0.83-1.13],0.713160749411955,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHGA,Chromogranin-A,Inverse variance weighted,5,0.94 [0.69-1.29],0.713569759184158,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.05 [0.81-1.35],0.714217942468286,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.94 [0.67-1.32],0.716093285225112,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.14 [0.55-2.39],0.718563961271941,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.11 [0.62-2.01],0.720510176910966,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.04 [0.83-1.3],0.721194512246972,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.16 [0.52-2.57],0.721364633367759,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CFP,Properdin,Inverse variance weighted,17,1.04 [0.85-1.25],0.722230297398393,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.95 [0.72-1.26],0.724855558672056,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,0.99 [0.91-1.07],0.725704521006834,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.06 [0.78-1.44],0.728577694147747,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,1.58 [0.12-20.94],0.729750968356348,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.05 [0.8-1.38],0.730102876753797,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.96 [0.76-1.21],0.732883660947025,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,0.91 [0.54-1.55],0.733730485029527,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CTSV,Cathepsin L2,Inverse variance weighted,34,1.02 [0.89-1.17],0.735409264112508,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,1.1 [0.64-1.89],0.735446291163557,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.01 [0.95-1.08],0.738037140712295,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,1.02 [0.91-1.14],0.739385978566144,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.96 [0.75-1.23],0.740844672577502,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.08 [0.69-1.68],0.741518174361854,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,UMOD,Uromodulin,Inverse variance weighted,34,1.02 [0.89-1.18],0.744829043441845,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,1.02 [0.89-1.17],0.744874115349949,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.89 [0.44-1.81],0.745786654737681,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.03 [0.88-1.2],0.746929874618979,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.03 [0.86-1.23],0.751985770962567,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.04 [0.81-1.33],0.756218415359893,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.94 [0.62-1.41],0.757570295663901,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GHR,Growth hormone receptor,Inverse variance weighted,26,1.03 [0.87-1.22],0.758108747506467,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,F3,Tissue factor,Inverse variance weighted,13,0.95 [0.66-1.35],0.762100777729434,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.01 [0.95-1.07],0.763545633853543,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.02 [0.89-1.17],0.764316085538283,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.96 [0.76-1.22],0.764711779227466,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLK4,Kallikrein-4,Inverse variance weighted,5,0.92 [0.53-1.59],0.765392091470376,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.97 [0.8-1.18],0.766159612912224,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.96 [0.74-1.25],0.769651978326329,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.03 [0.86-1.23],0.77083197519264,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.98 [0.87-1.11],0.772133099287051,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.06 [0.7-1.6],0.774261600916654,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.04 [0.78-1.41],0.775570814598804,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1.1 [0.57-2.14],0.776040830408548,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,POF1B,Protein POF1B,Inverse variance weighted,4,0.93 [0.57-1.52],0.778127608106486,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.98 [0.82-1.16],0.778281714773975,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.96 [0.69-1.32],0.78095449638724,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.9 [0.41-1.94],0.781971438991731,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,0.97 [0.8-1.18],0.782066477849201,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.96 [0.69-1.32],0.782157748503765,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.05 [0.73-1.52],0.783142813683751,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RGMB,RGM domain family member B,Inverse variance weighted,5,1.08 [0.63-1.84],0.784007418247688,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.08 [0.63-1.85],0.78418662132033,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.01 [0.92-1.12],0.784784208161484,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,XCL1,Lymphotactin,Inverse variance weighted,15,1.04 [0.79-1.37],0.786384904503149,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EGLN1,Egl nine homolog 1,Wald ratio,1,1.15 [0.42-3.13],0.79070681623244,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,BSG,Basigin,Inverse variance weighted,6,1.06 [0.68-1.66],0.792900768966341,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VWC2,Brorin,Inverse variance weighted,12,1.04 [0.77-1.42],0.793327865783792,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.93 [0.54-1.61],0.797058089971444,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPON1,Spondin-1,Inverse variance weighted,4,0.94 [0.61-1.46],0.799156507697325,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,RETN,Resistin,Inverse variance weighted,19,1.02 [0.85-1.24],0.799264187806548,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD27,CD27 antigen,Inverse variance weighted,9,0.96 [0.7-1.32],0.800960606937826,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,27,1.02 [0.89-1.16],0.804429152853659,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.96 [0.66-1.38],0.809934483252495,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DPT,Dermatopontin,Inverse variance weighted,4,0.93 [0.51-1.7],0.810537156585905,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.02 [0.88-1.18],0.813027749042819,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,0.97 [0.76-1.24],0.8134919525001,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.98 [0.86-1.12],0.815532774519616,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CFC1,Cryptic protein,Inverse variance weighted,11,1.03 [0.8-1.33],0.81564617288217,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.93 [0.53-1.65],0.815764325110072,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,1.02 [0.84-1.26],0.816020772244418,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.06 [0.64-1.75],0.817710107683678,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DRAXIN,Draxin,Inverse variance weighted,25,0.98 [0.82-1.17],0.818370501896227,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.97 [0.75-1.26],0.821286492284721,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.08 [0.54-2.18],0.821858816200453,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.97 [0.72-1.3],0.821981191718669,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.97 [0.76-1.24],0.822649951092949,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.06 [0.64-1.75],0.823549849568566,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SDC4,Syndecan-4,Inverse variance weighted,35,1.02 [0.87-1.2],0.824193764807242,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.05 [0.68-1.62],0.827679310595213,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.96 [0.66-1.39],0.828581613280542,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FBLN2,Fibulin-2,Inverse variance weighted,6,0.97 [0.7-1.33],0.830349404082071,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.02 [0.84-1.25],0.834473657117614,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,THBD,Thrombomodulin,Inverse variance weighted,11,0.98 [0.77-1.24],0.836597714990742,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,AMBP,Protein AMBP,Inverse variance weighted,5,0.97 [0.75-1.26],0.838410447283008,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.93 [0.47-1.84],0.840098270870734,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.02 [0.82-1.27],0.841284429305569,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,1.1 [0.43-2.84],0.841398094456908,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.09 [0.47-2.51],0.84334878466464,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PI3,Elafin,Inverse variance weighted,18,1.01 [0.88-1.17],0.846201948836946,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PALM,Paralemmin-1,Inverse variance weighted,4,0.92 [0.4-2.14],0.848814505770853,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,1.04 [0.72-1.5],0.854036771631718,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Wald ratio,1,0.87 [0.19-3.94],0.855573046304448,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,DSC2,Desmocollin-2,Inverse variance weighted,16,1.01 [0.89-1.15],0.857780727160159,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,1.03 [0.75-1.42],0.860163267224067,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.89 [0.26-3.13],0.861389053255987,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.04 [0.67-1.62],0.862259708504172,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.05 [0.57-1.95],0.865486249529135,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MSLN,Mesothelin,Inverse variance weighted,11,1.04 [0.68-1.57],0.871361700760903,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.07 [0.47-2.45],0.874573122767237,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MDK,Midkine,Inverse variance weighted,14,0.98 [0.78-1.23],0.877017369529943,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,REN,Renin,Inverse variance weighted,8,1.03 [0.69-1.54],0.878168900498788,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,7,0.98 [0.79-1.22],0.88571772748289,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,0.99 [0.86-1.14],0.886873190751298,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD83,CD83 antigen,Inverse variance weighted,14,1.02 [0.81-1.27],0.890962506858584,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,0.99 [0.9-1.09],0.891463403684537,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.99 [0.91-1.08],0.893350792724958,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.01 [0.92-1.1],0.893536024169305,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.98 [0.73-1.32],0.894096049411894,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.99 [0.79-1.23],0.89985648119254,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1.02 [0.76-1.36],0.900739176175473,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.99 [0.81-1.21],0.901701866462316,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.94 [0.36-2.45],0.902714352638818,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,S100P,Protein S100-P,Inverse variance weighted,4,0.98 [0.68-1.4],0.9027191194408,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PVR,Poliovirus receptor,Inverse variance weighted,3,0.96 [0.45-2.02],0.904986971801357,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.01 [0.83-1.24],0.905142885312772,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.01 [0.81-1.27],0.90554544235276,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,1.02 [0.74-1.4],0.909876540511791,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LMNB2,Lamin-B2,Inverse variance weighted,8,0.97 [0.58-1.62],0.913104606403404,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,0.99 [0.82-1.2],0.914507186340976,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.03 [0.57-1.87],0.914967870162307,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,KLKB1,Plasma kallikrein,Inverse variance weighted,20,1.01 [0.86-1.19],0.917993643224536,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1 [0.93-1.09],0.920100436843477,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.01 [0.84-1.21],0.920781699019926,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.99 [0.83-1.18],0.920785280291416,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.88-1.13],0.922084575401072,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.02 [0.74-1.39],0.922116689445076,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.98 [0.63-1.53],0.922439139351885,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.02 [0.72-1.44],0.923766887333694,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.99 [0.76-1.28],0.924607056708241,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRSS8,Prostasin,Inverse variance weighted,14,0.99 [0.8-1.23],0.929097502205201,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MILR1,Allergin-1,Inverse variance weighted,43,1 [0.95-1.05],0.930186977882783,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.02 [0.59-1.77],0.938765055048814,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SERPINB8,Serpin B8,Inverse variance weighted,29,1 [0.95-1.06],0.939251395205571,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.99 [0.76-1.29],0.939407303892606,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NRP1,Neuropilin-1,Inverse variance weighted,14,0.99 [0.75-1.3],0.940828417231846,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.02 [0.64-1.61],0.942759339533731,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Wald ratio,1,1.04 [0.33-3.3],0.942940827767893,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.96 [0.34-2.75],0.944174880914096,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.01 [0.73-1.4],0.944709088748855,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.01 [0.67-1.53],0.947423348193931,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.02 [0.6-1.73],0.94856636285565,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,0.99 [0.66-1.48],0.952175237295365,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,34,1 [0.92-1.09],0.956254619879528,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.01 [0.63-1.63],0.957174113178275,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.01 [0.79-1.28],0.958786286271293,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1 [0.93-1.08],0.959405747512369,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1 [0.9-1.1],0.959672054693371,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.01 [0.59-1.73],0.962176753606789,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CDH6,Cadherin-6,Inverse variance weighted,5,0.99 [0.65-1.51],0.965922588789111,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.01 [0.55-1.87],0.971102785360325,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TFF3,Trefoil factor 3,Inverse variance weighted,10,1 [0.78-1.28],0.972474277570203,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRSS2,Trypsin-2,Inverse variance weighted,17,1 [0.84-1.18],0.973645488258323,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PGA4,Pepsin A-4,Inverse variance weighted,7,1.01 [0.69-1.47],0.973697229620834,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,1 [0.95-1.05],0.973911305614271,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.99 [0.54-1.83],0.976229307113104,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,1.01 [0.5-2.05],0.977463958135413,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MUC13,Mucin-13,Inverse variance weighted,3,1.01 [0.5-2.05],0.979882552833456,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.99 [0.48-2.05],0.981144191270706,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1 [0.63-1.57],0.984335128725022,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,CLEC3B,Tetranectin,Inverse variance weighted,2,1.01 [0.46-2.18],0.987580490586357,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1 [0.72-1.4],0.988214469051664,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,PRTN3,Myeloblastin,Inverse variance weighted,20,1 [0.85-1.17],0.988928483459764,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,C7,Complement component C7,Inverse variance weighted,26,1 [0.92-1.09],0.989896441722395,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1 [0.88-1.14],0.991761426332107,trans
Chapter IX Diseases of the circulatory system,I9_HYPOTE,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1 [0.94-1.06],0.992272800096464,trans
